|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakamoto KM, Kim KB, Verma R, Ransick A,
Stein B, Crews CM and Deshaies RJ: Development of Protacs to target
cancer-promoting proteins for ubiquitination and degradation. Mol
Cell Proteomics. 2:1350–1358. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wei W and Lin H-K: The key role of
ubiquitination and sumoylation in signaling and cancer: A research
topic. Front Oncol. 2:1872012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamaguchi H, Hsu JL and Hung MC:
Regulation of ubiqui-tination-mediated protein degradation by
survival kinases in cancer. Front Oncol. 2:152012. View Article : Google Scholar
|
|
6
|
Vlachostergios PJ, Voutsadakis IA and
Papandreou CN: The ubiquitin-proteasome system in glioma cell cycle
control. Cell Div. 7:182012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ciechanover A: Intracellular protein
degradation: From a vague idea through the lysosome and the
ubiquitin-proteasome system and onto human diseases and drug
targeting. Bioorg Med Chem. 21:3400–3410. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wilde IB, Brack M, Winget JM and Mayor T:
Proteomic char-acterization of aggregating proteins after the
inhibition of the ubiquitin proteasome system. J Proteome Res.
10:1062–1072. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sawyer JR: The prognostic significance of
cytogenetics and molecular profiling in multiple myeloma. Cancer
Genet. 204:3–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu Z-Z, Wang D, Cong W-M, Jiang H, Yu Y,
Wen BJ, Dong H, Zhang X, Liu SF, Wang AZ, et al: Sex-related
differences in DNA copy number alterations in hepatitis B
virus-associated hepatocellular carcinoma. Asian Pac J Cancer Prev.
13:225–229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Naz RK and Dhandapani L: Identification of
human sperm proteins that interact with human zona pellucida3 (ZP3)
using yeast two-hybrid system. J Reprod Immunol. 84:24–31. 2010.
View Article : Google Scholar :
|
|
12
|
Madura K: The ubiquitin-associated (UBA)
domain: On the path from prudence to prurience. Cell Cycle.
1:235–244. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sakoda T, Kasahara N, Hamamori Y and Kedes
L: A high-titer lentiviral production system mediates efficient
transduction of differentiated cells including beating cardiac
myocytes. J Mol Cell Cardiol. 31:2037–2047. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Rahman NA, Bennink HJTC, Chrusciel M,
Sharp V, Zimmerman Y, Dina R, Li X, Ellonen A, Rivero-Müller A,
Dilworth S, et al: A novel treatment strategy for ovarian cancer
based on immunization against zona pellucida protein (ZP) 3. FASEB
J. 26:324–333. 2012. View Article : Google Scholar
|
|
16
|
Sudhir PR, Hsu CL, Wang MJ, Wang YT, Chen
YJ, Sung TY, Hsu WL, Yang UC and Chen JY: Phosphoproteomics
identifies oncogenic Ras signaling targets and their involvement in
lung adenocarcinomas. PLoS One. 6:e201992011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Olsen BB, Svenstrup TH and Guerra B:
Downregulation of protein kinase CK2 induces autophagic cell death
through modulation of the mTOR and MAPK signaling pathways in human
glioblastoma cells. Int J Oncol. 41:1967–1976. 2012.PubMed/NCBI
|
|
18
|
Bank A, Dorazio R and Leboulch P: A phase
I/II clinical trial of beta-globin gene therapy for
beta-thalassemia. Ann N Y Acad Sci. 1054:308–316. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fang J, Yu Z, Lian M, Ma H, Tai J, Zhang L
and Han D: Knockdown of zinc finger protein, X-linked (ZFX)
inhibits cell proliferation and induces apoptosis in human
laryngeal squamous cell carcinoma. Mol Cell Biochem. 360:301–307.
2012. View Article : Google Scholar
|
|
20
|
Sherr CJ: The Pezcoller lecture: Cancer
cell cycles revisited. Cancer Res. 60:3689–3695. 2000.PubMed/NCBI
|
|
21
|
Piva R, Cancelli I, Cavalla P, Bortolotto
S, Dominguez J, Draetta GF and Schiffer D: Proteasome-dependent
degradation of p27/kip1 in gliomas. J Neuropathol Exp Neurol.
58:691–696. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pamarthy D, Tan M, Wu M, Chen J, Yang D,
Wang S, Zhang H and Sun Y: p27 degradation by an ellipticinium
series of compound via ubiquitin-proteasome pathway. Cancer Biol
Ther. 6:360–366. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Amador V, Ge S, Santamaría PG,
Guardavaccaro D and Pagano M: APC/C(Cdc20) controls the
ubiquitin-mediated degradation of p21 in prometaphase. Mol Cell.
27:462–473. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
An J, Yang DY, Xu QZ, Zhang SM, Huo YY,
Shang ZF, Wang Y, Wu DC and Zhou PK: DNA-dependent protein kinase
catalytic subunit modulates the stability of c-Myc oncoprotein. Mol
Cancer. 7:322008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ying H and Xiao ZX: Targeting
retinoblastoma protein for degradation by proteasomes. Cell Cycle.
5:506–508. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ohgaki H and Kleihues P: Genetic pathways
to primary and secondary glioblastoma. Am J Pathol. 170:1445–1453.
2007. View Article : Google Scholar : PubMed/NCBI
|
